Cargando…
Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiar...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258560/ https://www.ncbi.nlm.nih.gov/pubmed/34226216 http://dx.doi.org/10.1136/bmjopen-2020-045895 |
_version_ | 1783718521106071552 |
---|---|
author | Sharp, Rebecca Carr, Peter Childs, Jessie Scullion, Andrew Young, Mark Flynn, Tanya Kirker, Carolyn Jackson, Gavin Esterman, Adrian |
author_facet | Sharp, Rebecca Carr, Peter Childs, Jessie Scullion, Andrew Young, Mark Flynn, Tanya Kirker, Carolyn Jackson, Gavin Esterman, Adrian |
author_sort | Sharp, Rebecca |
collection | PubMed |
description | OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiary hospitals in Australia and New Zealand. PARTICIPANTS: Adults who had undergone PICC insertion. PRIMARY OUTCOME MEASURE: Symptomatic thrombus of the limb in which the PICC was inserted. RESULTS: 2438 PICC insertions were included with 39 cases of thrombosis (1.6%; 95% CI 1.14% to 2.19%). Receiver operator characteristic analysis was unable to be performed to determine the optimal CVR overall or according to diagnosis. The association between risk of thrombosis and CVR cut-offs commonly used in clinical practice were analysed. A 45% cut-off (≤45% versus ≥46%) was predictive of thrombosis, with those with a higher ratio having more than twice the risk (relative risk 2.30; 95% CI 1.202 to 4.383; p=0.01). This pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a CVR greater than 45%. Whereas the 33% CVR cut-off was not associated with statistically significant results overall or in those with malignancy. Neither the 33% or 45% CVR cut-off produced statistically significant results in those with infection or other non-malignant conditions. CONCLUSIONS: Adherence to CVR cut-offs are an important component of PICC insertion clinical decision making to reduce the risk of thrombosis. These results suggest that in individuals with cancer, the use of a CVR ≤45% should be considered to minimise risk of thrombosis. Further research is needed to determine the risk of thrombosis according to malignancy type and the optimal CVR for those with a non-malignant diagnosis. |
format | Online Article Text |
id | pubmed-8258560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82585602021-07-23 Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study Sharp, Rebecca Carr, Peter Childs, Jessie Scullion, Andrew Young, Mark Flynn, Tanya Kirker, Carolyn Jackson, Gavin Esterman, Adrian BMJ Open Nursing OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiary hospitals in Australia and New Zealand. PARTICIPANTS: Adults who had undergone PICC insertion. PRIMARY OUTCOME MEASURE: Symptomatic thrombus of the limb in which the PICC was inserted. RESULTS: 2438 PICC insertions were included with 39 cases of thrombosis (1.6%; 95% CI 1.14% to 2.19%). Receiver operator characteristic analysis was unable to be performed to determine the optimal CVR overall or according to diagnosis. The association between risk of thrombosis and CVR cut-offs commonly used in clinical practice were analysed. A 45% cut-off (≤45% versus ≥46%) was predictive of thrombosis, with those with a higher ratio having more than twice the risk (relative risk 2.30; 95% CI 1.202 to 4.383; p=0.01). This pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a CVR greater than 45%. Whereas the 33% CVR cut-off was not associated with statistically significant results overall or in those with malignancy. Neither the 33% or 45% CVR cut-off produced statistically significant results in those with infection or other non-malignant conditions. CONCLUSIONS: Adherence to CVR cut-offs are an important component of PICC insertion clinical decision making to reduce the risk of thrombosis. These results suggest that in individuals with cancer, the use of a CVR ≤45% should be considered to minimise risk of thrombosis. Further research is needed to determine the risk of thrombosis according to malignancy type and the optimal CVR for those with a non-malignant diagnosis. BMJ Publishing Group 2021-07-05 /pmc/articles/PMC8258560/ /pubmed/34226216 http://dx.doi.org/10.1136/bmjopen-2020-045895 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Nursing Sharp, Rebecca Carr, Peter Childs, Jessie Scullion, Andrew Young, Mark Flynn, Tanya Kirker, Carolyn Jackson, Gavin Esterman, Adrian Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title | Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title_full | Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title_fullStr | Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title_full_unstemmed | Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title_short | Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study |
title_sort | catheter to vein ratio and risk of peripherally inserted central catheter (picc)-associated thrombosis according to diagnostic group: a retrospective cohort study |
topic | Nursing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258560/ https://www.ncbi.nlm.nih.gov/pubmed/34226216 http://dx.doi.org/10.1136/bmjopen-2020-045895 |
work_keys_str_mv | AT sharprebecca cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT carrpeter cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT childsjessie cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT scullionandrew cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT youngmark cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT flynntanya cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT kirkercarolyn cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT jacksongavin cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy AT estermanadrian cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy |